An Open Label Study to Investigate the Efficacy and Safety of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients with Stage IB, II, IIIA, or Selected IIIB Resectable and Untreated NonSmall Cell Lung Cancer (GO40241)
An Open Label Study to Investigate the Efficacy and Safety of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients with Stage IB, II, IIIA, or Selected IIIB Resectable and Untreated NonSmall Cell Lung Cancer (GO40241)
Trial Category:
Lung
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
